An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia

Inclusion Criteria

• •Patients must be between 18 and 85 years of age, with a stable living situation
• •Clinical diagnosis of either primary insomnia or "secondary" insomnia (comorbid with depression, anxiety, and/or medical illness)
• •Insomnia systems must be at least moderate in severity within the month prior to study entry, and must include difficulty staying asleep and/or problems with awakening earlier than desired
• •Psychiatric and medical conditions present must be stable over the 3 months prior to study entry, and not expected to worsen significantly or require hospitalization during participation in the study
• •Ongoing treatments for psychiatric and medical conditions present must have been stable for the 3 months prior to study entry, and must be expected to remain stable during participation in the study
• •Patients must be willing to abstain from taking medications (other than study drug) to help them sleep during participation in the study
• •Patients must be willing to consistently spend at least 7 hours each night either sleeping or trying to sleep during participation in the study
• •Patients must be able to speak and read English and be capable of using a computer with a web browser (computers with internet connections will be provided to patients who need them)